No shares dematerialised in July 2026, total demat count unchanged at 6.11 crore

Compliance View source PDF Explain this filing

PANACEABIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-0.3%1-day move

₹420.40

prior close

₹427.00

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.5-0.4-0.3-0.2-0.3-1.9-4.0-4.2-4.8-5.6-5.3-9.8——

Up moveDown movePending

AI summary

Panacea Biotec filed a routine monthly demat report with BSE, NSE and the two depositories. The company confirmed that no shares were dematerialised during July 2026. Total dematerialised shares stood unchanged at 6,11,05,526 as on 31 July 2026, identical to 30 June 2026. Of these, NSDL holds 5,26,65,454 shares and CDSL holds 84,40,072 shares. This is a standard SEBI compliance filing under Regulation 74(5) of the Depositories and Participants Regulations, 2018, supported by an RTA certificate from Skyline Financial Services.

Likely market impact

Routine regulatory compliance filing with no material impact on shareholding, trading activity or stock price.